Research & Development

哥哥坏妹妹爱哥哥爱色阁色哥哥在线影院快讯:科创板成交额迅速破100亿元 较昨日提早45分钟


  雲氏新開發的蠶絲項目帶來的榮光,轉瞬間就被太陽光一般的大捷消息所籠罩。   “有這樣的工藝?”劉徹大為驚奇。哥哥坏妹妹爱   “查,淮南王府中還有誰與劉陵交好,或者在其余人犯中有誰可以讓劉陵重視的人。”哥哥爱色阁 第九十章 世上最執著的感情是仇恨 色哥哥在线影院

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo